LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2019

Conditions
Ischemic Heart Failure
Interventions
DEVICE

LifeVest

LifeVest monitors patients for VT/VF, notifies the patient if VT/VF occurs, and instructs them to press response buttons. In unresponsive patients, LifeVest delivers defibrillation therapy.

Trial Locations (1)

14642

University of Rochester Medical Center, Rochester

All Listed Sponsors
collaborator

University of Rochester

OTHER

lead

Zoll Medical Corporation

INDUSTRY

NCT02700880 - LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry | Biotech Hunter | Biotech Hunter